The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Erdafitinib in pediatric patients with advanced solid tumors with fibroblast growth factor receptor (FGFR) gene alterations: RAGNAR study pediatric cohort.
 
Olaf Witt
Honoraria - Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; BMS; Day One Therapeutics; Janssen Research & Development (Inst); Novartis; Roche; SK Life Sciences
Research Funding - BioMed Valley Discoveries (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Janssen Research & Development (Inst); MSD Oncology (Inst); PreComb Therapeutics (Inst)
 
Birgit Geoerger
Consulting or Advisory Role - AZD; Boehringer Ingelheim; Novartis
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst)
 
Sameer Farouk Sait
Consulting or Advisory Role - AstraZeneca
(OPTIONAL) Uncompensated Relationships - QED therapeutics
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox
 
Kent C. Shih
Honoraria - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Blanca D. Diez
No Relationships to Disclose
 
Eliana Maria Monteiro Caran
No Relationships to Disclose
 
Shuhei Karakawa
No Relationships to Disclose
 
Kim Stuyckens
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - Janssen
 
Huimin Liao
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Honoraria - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
 
Saltanat Najmi
Employment - Amgen; Johnson & Johnson; Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - Amgen
 
Constance Hammond
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Ademi E. Santiago-Walker
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - Janssen
 
Hussein Sweiti
Employment - Janssen Research & Development